News Articles 121 - 130 of 160
A new report highlights how alcohol producers worked to circumvent legislation designed to protect children during the UEFA Euro 2016 football tournament. Researchers at the Institute for Social Marketing, University of Stirling, found over 100 alcohol marketing references per televised match programme in three countries – France, the UK and Ireland. Most marketing appeared in highly visible places, such as pitch-side advertising during the matches. This was the case, despite the fact that the tournament was held in France, where alcohol TV advertising and sports sponsorship is banned under the ‘Loi Évin’.
The report, Foul Play? Alcohol marketing during UEFA Euro 2016, will be launched at the European Healthy Stadia conference at Emirates Stadium on Thursday 27th April.
An analysis of broadcast footage found that alcohol marketing appeared, on average, once every other minute. The majority took the form of ‘alibi’ marketing, whereby indirect brand references are used to promote a product, rather than a conventional logo or brand name. Carlsberg was the most featured brand, accounting for almost all references in each of the three countries, using their slogan ‘Probably the best in the world’ while avoiding the mentioning the product name. ‘Alibi’ marketing was a common practice of tobacco companies in sporting events when advertising restrictions were introduced.
Dr. Richard Purves, Principal Investigator, Institute for Social Marketing, University of Stirling said:
“Beamed to audiences across the world, major sporting events such as the UEFA EURO tournament, present a prime opportunity for alcohol companies to market directly to a global audience. In order to continue to protect children and young people from exposure to alcohol marketing, laws such as those in France need to be upheld and respected by all parties involved and not seen as something to be negotiated.”
Katherine Brown, Director of the Institute of Alcohol Studies said:
“There is strong evidence that exposure to alcohol marketing encourages children to drink earlier and in greater quantities. The findings of this report show that alcohol companies are following in the footsteps of their tobacco colleagues by bending the rules on marketing restrictions putting children’s health at risk.”
Eric Carlin, Director of Scottish Health Action on Alcohol Problems (SHAAP), said:
“Sport should be an alcohol-free space. The presence of alcohol marketing during UEFA EURO 2016 highlights that organisers of sporting events need to hold out against tactics of big alcohol companies to flout legal regulations designed to protect children.”
A copy of the full report is available here: https://bit.ly/alcfoulplay .
The research was carried out by the Institute for Social Marketing, University of Stirling, and funded by the Institute of Alcohol Studies (IAS), Scottish Health Action on Alcohol Problems (SHAAP), and Alcohol Action Ireland.
Interviews available on request in England, Scotland and Ireland. Please contact Habib Kadiri at firstname.lastname@example.org or 0207 222 4001.
NICE has published a press release announcing a draft quality standard which recommends that healthcare staff working in prisons should offer testing for blood-borne viruses like hepatitis B and C, and HIV to people upon entry to prison. It also recommends that they should also assess inmates for their risk of having a sexually transmitted infection (STI).
The press release can be read – here.
Bursaries are available for nonclinical students to attend the BSG 2017 Translational Science Masterclass (Thursday 22 June 2017, Manchester).
A restricted education fund provided by MSD provides ten £50 bursaries to nonclinical scientists who are:
(1) studying towards a higher degree in a gastroenterology-related area
(2) are not members of the BSG
(3) have registered to attend the Translational Science Masterclass only (Signalling in epithelial cancer and inflammation, Thursday 22 June 2017, Manchester)
Apply to the BSG Education Committee email@example.com by Monday 22 May.
The bursaries are available on a first-come, first-served basis.
The UK National Screening Committee (UK NSC) has carried out a national consultation on screening for Alcohol Misuse.
After reviewing comments from stakeholders (including BASL) and the consultation papers the UK NSC have made formal screening recommendations to the four UK countries.
The outcome of the consultation can be found on the UK NSC website here - http://screening.nhs.uk/alcohol .
Screening recommendations were made to the following conditions:
Fetomaternal alloimmune thrombocytopenia
There is more information about the work and remit of the UK NSC at http://www.screening.nhs.uk/about.
The Advisory Committee on Clinical Excellence Awards (ACCEA) opened the 2017 awards round on Tuesday 28th February. The final closing date for applications to the ACCEA is 17:00 on Tuesday 25th April 2017.
Application for BASL support
BASL will need to complete the process of selecting applicants who will receive our support shortly. If you would like to apply for BASL support please complete and submit Application Form A to BASL along with any other supplementary CVQs available as detailed below:
Form A – Application Form
Form D – Supplementary CV Questionnaire: Research & Innovation Assessment
Form E – Supplementary CV Questionnaire: Teaching & Training Assessment
Form F – Supplementary CV Questionnaire: Leadership & Management Assessment
In addition BASL also requires a short piece with your application on why you feel you should be supported by BASL.
The deadline for applying for BASL support is 17:00 on Friday 31st March 2017.
All applications have to go through the ACCEA on line system, however downloadable forms to send to BASL can be found on the ACCEA website by clicking > here.
Please be aware that there is a maximum number of supplementary forms that can be completed at each National Level: Bronze and Silver applicants: 1 and Gold applicants: 2. These forms are optional and it is for the applicant to decide whether using them will increase chances of success.
(For use of the Supplementary Forms, please see 'Domains' within the Application form A). Full application guidance can be found on the ACCEA website by clicking > here.
As in previous years BASL would be able to support colleagues directly by nomination for national Gold, Silver and Bronze awards. As a specialist society, BASL cannot make nominations for Platinum awards; this must be done through the applicant’s University/Research Body and Universities UK. BASL can however provide a citation to support an application for a Platinum award.
As a rule, candidates for National Bronze (Level 9) should have a minimum of at least five local Clinical Excellence Awards. Award holders applying for higher level awards or a renewal must specify which achievements have been made after the date of their last award or renewal particularly concentrating on current activities and activities in the last 4 or 5 years, therefore you must date activities.
To apply for BASL support, please follow these steps:
1. Send a completed application form along with a short piece as to why you feel you should be supported to the BASL Secretariat, Judy.Hawksworth@execbs.com by 17:00 on Friday 31st March 2017 for review.
Please understand that in fairness to all applicants, late submissions will not be considered.
2. All applicants will be asked to provide the name of an individual who could write a supporting citation upon submitting their application to BASL. ACCEA regard the citations provided in support of individuals as giving added value to the process. The citation MAY be stronger if it comes from outside ones institution.
3. You must submit your own application to ACCEA online by their deadline 17:00 on Tuesday 25th April. This is your own responsibility.
4. If you are in receipt of BASL support then BASL will upload your citation - please can you ensure your application is uploaded at least one week before the ACCEA deadline - before 17:00 on Tuesday 18th April 2017, so that we have sufficient time to upload your citations onto your application on the ACCEA website.
Congratulations to the liver nurses who were shortlisted at the BJN Awards for the Hepatology/Liver Nurse Award:
1st place: Tara Rees
Tara developed a nurse-led paracentesis service for patients with advanced liver disease and has shared her protocols across Wales.
2nd place: Linda Porter and Sarah Tarff
Linda and Sarah provide an innovative community HCV clinic that has allowed for contact and treatment of a large and hitherto poorly served and socially disadvantaged population with significant disease burden and largely preventable health-economic impact to the wider NHS.
3rd place: Michelle Clayton
Michelle has recently been approached as one of only seven nurses in Europe to set up a Concerted Action Group for the European Association of the Study of the Liver.
Photos of the event can be viewed > here.
BASLNF and BLNF Merger – Survey Results
A big thank you to all those who completed the recent survey regarding the proposed merger of the BASLNF with the BLNF. We now have the results and I can confirm that 100% of those who completed the survey support the merger.
In the next few weeks I will be back in touch with more details on the timelines for the merger, including the priorities for the new group; launch dates and membership details. I will ensure that this is all as seamless as possible.
The survey has given us a lot of ideas on areas where we need to be focusing on in the future and as always I welcome your input and suggestions.
Public Health England (PHE) has published its updated report on Hepatitis C in England, the documents for which can be found > here.
Additionally, Dr. Helen Harris from PHE has written a blog to mark the report’s publication. It states that they are on track to meet the new World Health Organisation’s target to reduce hepatitis C mortality by 10% by 2020, but stresses the need for improved diagnostics and case finding.